AbbVie Announces First Regulatory Approval of SKYRIZI™ (risankizumab) for the Treatment...
NORTH CHICAGO, Ill., March 26, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that th
European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease
Source: globenewswire.com
The European Commission has given approval to Roche’s drug MabThera (rituximab). This drug helps treat adults with moderate to severe pemphigus vulgaris (PV),...
Novartis announces new CEO of Oncology Business Unit
Novartis have appointed Susanne Schaffert, Ph.D., as the new CEO of Novartis Oncology Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019. Liz Barrett will be...
Spark Therapeutics’ One-time Gene Therapy LUXTURNA Gets EU Approval
Spark Therapeutics (ONCE), a commercial gene therapy company, announced Friday that the European Commission has granted marketing authorization for LUXTURNA (voretigene neparvovec).
